RLT
0.75
134.4%
88E
0.001
-50%
H2G
0.006
100%
NRZ
0.001
-50%
WOA
0.029
61.1%
TOU
0.008
-46.7%
PR2
0.079
33.9%
ALM
0.003
-40%
CTN
0.004
33.3%
CKA
0.036
-40%
BEZ
0.037
32.1%
ANR
0.007
-36.4%
STN
0.255
27.5%
DTM
0.004
-33.3%
SHO
0.028
27.3%
ECT
0.002
-33.3%
MLX
0.665
26.7%
NTM
0.002
-33.3%
AGR
0.049
25.6%
PUA
0.007
-30%
SMX
0.049
25.6%
OVT
0.005
-28.6%
AZY
0.47
25.3%
ID8
0.008
-27.3%
ADG
0.005
25%
CYB
0.073
-27%
LEG
0.01
25%
SLH
1.54
-22.2%
NMG
0.015
25%
OEC
0.09
-21.7%
VMC
0.12
25%
SNX
0.018
-21.7%
WSR
0.01
25%
RML
0.011
-21.4%
RWL
0.28
24.4%
RMS
2.2
-21.1%
EGR
0.155
24%
BSX
0.057
-20.8%
PSC
0.105
23.5%
CUE
0.1
-20%

What’s Hot – BPH, AGC, LTP, TPW, PRA, QML, 3DA, RAU, WTM & TYP

What’s Hot, Not & Doing
Brought to you by TSN Contributor & Wealth Advisor Nick Kelso

What’s Hot – BPH, AGC, LTP, TPW, PRA, QML, 3DA, RAU, WTM & TYP
What’s Not – SEK

What’s Hot
BPH – BPH Energy Limited today closed up 39% to finish at 2.6c on $440k stock traded. There was no news out today but yesterday they announced a placement to raise $1.044m @ 1.8c through the boys and girls at Oakley Capital Partners & 62 Capital.

The funds raised will provide BPH with a strong cash position to fund its hydrocarbon projects and to assist in the continued development of Cortical Dynamics.

The follows news last week that its subsidiary Asset Energy had filed an originating application for judicial review in the Federal Court.

AGC – Australian Gold and Copper Limited today closed up 32% to finish at 29c on $530k stock traded. The reason they were up today was because they released a change of director’s interest notice.

Zhang Young purchased 18.9m shares in the last placement valued at $6.05m, Mr Yong now holds 141m shares for a 55% interest in the company.

Last week, AGC announced an exploration update from the Achilles Prospect within its Cargelligo Project located in Cobar, NSW.

AGC commenced an extensive IP geophysical survey designed to test for further sulphide targets to the south of the Achilles discovery.

LTP – LTR Pharma Limited today closed up 29% to finish at $1.245 on $7m stock traded. The reason they were up today was because they announced a co-development agreement was entered with Aptar Pharma.

Aptar Pharma (US$9.5 billion market cap) is a trusted partner to many pharmaceutical companies to bring drug delivery solutions to market quickly and efficiently.

Aptar Pharma has supported numerous market authorisation holders in obtaining their combination drug-device product approvals incorporating Aptar’s nasal delivery systems from regulatory agencies such as the FDA.

TPW – Temple & Webster Limited today closed up 23% to finish at $11.71 on $22.5m stock traded. The reason they were up today was because they released its full year results which highlighted a 26% increase in revenue to $498m.

Growth was driven by active customers which were up 31% to an all-time high of 1.1m, this helped them deliver EBITDA at the top end of the guidance of $13.1m and at a 2.6% margin.

Repeat customers now make up 57% of all orders, growth horizons of B2B and home improvement grew strongly up 27% and 26% respectively.

Temple & Webster also announces the appointment of Cameron Barnsley as Chief Financial Officer.

TPW – Temple & Webster Limited today closed up 23% to finish at $11.71 on $22.5m stock traded. The reason they were up today was because they released its full year results which highlighted a 26% increase in revenue to $498m.

Growth was driven by active customers which were up 31% to an all-time high of 1.1m, this helped them deliver EBITDA at the top end of the guidance of $13.1m and at a 2.6% margin.

Repeat customers now make up 57% of all orders, growth horizons of B2B and home improvement grew strongly up 27% and 26% respectively.

ORA – Orora Limited today closed up 19% to finish at $ 2.27on $128m stock traded. The reason they were up today was because they announced a non-binding indicative offer (NBIO) was received from Lone Star Fund XII Acquisitions to be acquired for $2.55 by way of scheme of arrangement.

Lone Star Fund XII has approximately $5.3 billion in capital commitments, their transactions targeted include opportunistic investments in portfolio companies, financial institutions and portfolios of loans across North America, Europe and Asia Pacific.

The Board together with its advisers, carefully considered the NBIO and determined that it is not in the best interests of its shareholders as it materially undervalues Orora.

QML – Qmines Limited today closed up 19% to finish at 5.6c on $110k stock traded. The reason they were up today was because they announced drilling had commenced at its Develin Creek project located nearby to its flagship Mt Chalmers Project in QLD.

Site access tracks and the construction of drill pads is nearing completion with a RC drill rig mobilised to site with drilling operations expected to commence this week.

The program will focus on infill resource definition drilling at the existing Sulphide City and Scorpion resources with an aim of converting the largely inferred resource of 3.2Mt @ 1.05% Cu, 1.22% Zn, 0.17g/t Au & 5.9g/t Ag into an indicated resource.

3DA – Amaero International Limited today closed up 17% to finish at 38c on $690k stock traded. There was no news out today but late last month they released its quarterly which highlighted the commissioning of its atomiser was completed ahead of schedule.

The atomiser was installed and tested in accordance with technical specifications in the purchase agreement, 3DA’s technical and manufacturing team will now commence proprietary modifications of the atomisation process and optimization of the operating parameters.

This important milestone helps position Amaero as the largest U.S. domestic producer of C103 and specialty alloy AM powders.

RAU – Resouro Strategic Metals Limited today closed up 12% to finish at 41c on $370k stock traded. The reason they were up today was because they announced metallurgical test results from its Tiros Titanium and Rare Earth Elements Project located in Brazil.

RAU assessed an approximately 50kg representative sample, covering five diamond drill holes of the Tiros JORC compliant resource of 1.7Bt @ 3,900 ppm total rare earth oxides (TREO) & 12% TiO2.

Met work produced extraction results of 80.8% TREY, 81.6% LREE (light rare earths), 96.2% MREE (magnet rare earths) & 74.8% HREE (heavy rare earths).

Resouro believes they have the potential to achieve the highest rare earth extractions known across the industry to date.

WTM – Waratah Minerals Limited today closed up 12% to finish at 33c on $3.5m stock traded. There was no news out today but earlier this month they announced assay results from its Spur Project located in the Lachlan Fold Belt, NSW.

Results received from a further six holes intersected up to 89m @ 1.73g/t Au, 0.08% Cu from 115m including 57m @ 2.50g/t Au, 0.11% Cu from 115m.

The maiden RC drilling program at Spur was designed to test extensions of shallow epithermal gold mineralisation and investigate a potential link with an alkalic porphyry gold-copper system down plunge.

TYP – Tryptamine Therapeutics Limited today closed up 11% to finish at 2.1c on $100k stock traded. There was no news out today but yesterday they announced positive results from its recently completed Phase 2a clinical trial to evaluate TRP-8802 (oral psilocybin) in conjunction with psychotherapy in patients with fibromyalgia.

Fibromyalgia is a condition associated with widespread pain, 1m people in Australia & ~10m people in the US suffer from it with limited treatment options, the global market is valued at US$2.8b.

All patients dosed with TRP-8802 and administered psychotherapy reported an improvement in fibromyalgia pain severity, sleep, pain interference and at least 3 other endpoints measured one month after dosing.

What’s Not
SEK – Seek Limited today closed down 6.9% to finish at $20.66 on $185m stock traded. The reason they were down today was because they released its full year results which revealed a 33% fall in adjusted net profit after tax (NPAT) to $177.4m.

The significant decline in reported NPAT is due to a previously announced Zhaopin impairment and 9% reduction in valuation of the SEEK Growth Fund.

The impairment charge related to their investment in Zhaopin was valued at $141m, as a result of challenging macroeconomic conditions and an increasingly competitive environment.

Rats Rant – IMPORTANT INFORMATION
The idea of this report is to be informative and hopefully point out some stocks that you wouldn’t ordinarily have seen during the day, maybe even have a laugh too.This report IS NOT personal advice. Sanlam Private Wealth Pty Ltd DOES NOT PROVIDE personal advice, Sanlam Private Wealth provides General Financial Product Advice.All advice included in The Rat’s Rant is General Advice. Please refer to the General Advice Warning. The views expressed in this report are my views and may not necessarily reflect the same views as Sanlam Private Wealth.It is very important to refer to the ASX website for information on any companies / stock that are contained in this report and as always please consult your financial adviser before acting.

Important Notice
Rat Consulting Pty Ltd (ABN 81 148 181 588 ) Authorised Representative (No 001281456) of Sanlam Private Wealth Ltd (ABN 18 136 960 775) holder of Australian Financial Services Licence (AFSL 337 927).